Abstract
The microbiological transformation ofN-heptyl physostigmine (L-693, 487) (1), a semisynthetic physostigmine cholinesterase inhibitor, was investigated usingVerticillium lecanii MF 5713 (ATCC 74148),Acremonium sp MF 5723 (ATCC 74164) andActinoplanes sp MA 6559 (ATCC 53771). Nine microbial metabolites (2–10) of 1 were isolated and purified using reversed-phase HPLC. The structures of the metabolites were established using spectroscopic techniques including MS and NMR. Some of the microbial metabolites were identical to metabolites present in urine of a dog treated with 1.
Similar content being viewed by others
References
Anonymous. 1991. Synapton promising in Alzheimer's? Script no 164322.
Brufani M, C Castellano, M Marta, A Oliverio, F Pavone and M Pomponi. 1989. Physostigmine derivatives with acetylcholinesterase inhibition properties, and manufacture. US Patent no 4831155 (CA 110: 146935v).
Hichens M, HGP Kari and KP Vyas. 1993. Hexahydropyrrolo[2,3-B]indole derivatives. US Patent no 5206260 (CA 119: 66604g).
Iwasa T, S Harada and Y Sato. 1981. Miticidal antibiotics C-8030 B, C, D and physostigmine produced byStreptomyces pseudogriseolus subspiriomotensi subsp nov. J Takeda Res Lab 40: 1226.
Jobst J and O Hesse. 1964. Ueber die bohne von Calabar. Liebig Ann 129: 115–121.
Johnson CD and RL Russell. 1975. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Analyt Biochem 64: 229–238.
Smith RV and JP Rosazza. 1975. Microbial models of mammalian metabolism. J Pharm Sci 64: 1737–1759.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
So, L., White, R., Arison, B. et al. Microbial transformation ofN-heptyl physostigmine, a semisynthetic alkaloid inhibitor of cholinesterase. Journal of Industrial Microbiology 15, 108–111 (1995). https://doi.org/10.1007/BF01569808
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01569808